Viewing Study NCT07389733


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 3:20 AM
Study NCT ID: NCT07389733
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-02
First Post: 2026-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module